Oncology

Study title:

Comparison of nivolumab in combination with ipilimumab with standard therapy (Extreme Study Regimen) as first-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck region (CheckMate 651)

Indication

palliative, first line

Type of study

randomised, 2-arm, open

Study status

active, recruiting

Study phase

phase III

Sponsor

Bristol-Myers Squibb

PI

PD Dr Simon Laban

Deputy PI

PD Dr Jan Krönke

Contact

studienzentrale.hno@uniklinik-ulm.de

Further information

clinicaltrials.gov/ct2/show/NCT02741570

 

 

 

 

Study title

Pembrolizumab (MK-3475) as first-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck region (MK-3475-048/KEYNOTE-048)

Indication

palliative, first line

Type of study

randomised, 3-arm, open

Study status

active, not recruiting

Study phase

phase III

Sponsor

Merck Sharp & Dohme Corp.

PI

PD Dr Simon Laban

Deputy

Dr Johannes Döscher

Contact Dr Johannes Döscher

studienzentrale.hno@uniklinik-ulm.de

Further information

clinicaltrials.gov/ct2/show/NCT02358031

 

Study title

Pembrolizumab (MK-3475) or placebo in combination with platinum-based chemoradiotherapy for patients with locoregionally advanced squamous cell carcinoma of the head and neck region (MK-3475-412/KEYNOTE-412)

Indication

curative, primary radiochemotherapy

Type of study

randomised, 2-arm, blinded

Study status

active, recruiting

Study phase

phase III

Sponsor

Merck Sharp & Dohme Corp.

PI

PD Dr Simon Laban

Deputy

Prof Dr Thomas Wiegel

Contact Prof. Dr. Thomas Wiegel

studienzentrale.hno@uniklinik-ulm.de

Further information

clinicaltrials.gov/ct2/show/NCT03040999

 

Study title

Split or full-thickness skin to cover the lifting defect after removal of a radialis graft

Indication

Surgery with radialis graft

Type of study

randomised, 2-arm, open

Study status

active, recruiting

Study phase

not AMG

Sponsor

University Hospital Ulm

PI

PD Dr Jens Greve

Deputy

Prof Dr Thomas K. Hoffmann

contact

studienzentrale.hno@uniklinik-ulm.de

 

Study title

Comparison of the effectiveness of transoral surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal carcinoma

Indication

curative, transorally resectable oropharyngeal cancer

Type of study

randomised, 2-arm, open

Study status

active, recruiting

Study phase

phase III

Sponsor

University Medical Centre Hamburg Eppendorf

PI

PD Dr Simon Laban

Deputy PI

Prof Dr Thomas Wiegel

contact

studienzentrale.hno@uniklinik-ulm.de

Further information

www.clinicaltrialsregister.eu/ctr-search/trial/2016-002163-34/DE

 

Study title

Subcutaneous wound closure with V-LOC suture material compared to wound closure with Vicryl suture material

Indication

Bilateral neck dissection

Type of study

randomised, 2-arm, open

Study status

active, recruiting

Study phase

not AMG

Sponsor

University Hospital Ulm

PI

Dr Johannes Döscher

Deputy

Prof Dr Thomas K. Hoffmann

contact

studienzentrale.hno@uniklinik-ulm.de

 

  • ACC
  • BREG
  • Genetics
  • HNU